ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,482,055 | +77862.5% | 1,732,571 | 0.0% | 0.56% | -10.6% |
| Q2 2023 | $13,445 | +123.8% | 1,732,571 | +64.4% | 0.62% | +111.5% |
| Q1 2023 | $6,008 | -99.9% | 1,054,000 | 0.0% | 0.30% | -24.0% |
| Q4 2022 | $7,362,401 | +118.3% | 1,054,000 | 0.0% | 0.39% | +104.2% |
| Q3 2022 | $3,373,000 | -28.6% | 1,054,000 | 0.0% | 0.19% | -36.5% |
| Q2 2022 | $4,722,000 | -16.1% | 1,054,000 | 0.0% | 0.30% | +3.5% |
| Q1 2022 | $5,628,000 | +91.4% | 1,054,000 | +427.0% | 0.29% | +153.5% |
| Q4 2021 | $2,940,000 | -29.7% | 200,000 | 0.0% | 0.11% | -21.9% |
| Q3 2021 | $4,182,000 | +18.2% | 200,000 | 0.0% | 0.15% | +16.8% |
| Q2 2021 | $3,538,000 | -27.8% | 200,000 | 0.0% | 0.12% | -24.7% |
| Q1 2021 | $4,900,000 | -27.6% | 200,000 | 0.0% | 0.17% | -23.9% |
| Q4 2020 | $6,770,000 | – | 200,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |